Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors

Molecular Pharmacology

Volumn 56, Issue 6, 1999, Pages 1245-1253

  Gnagey, Ann L ^a,b   Seidenberg, Margaret ^a   Ellis, John ^a,c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b Vermont Technical College   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR AFFINITY; SITE DIRECTED MUTAGENESIS;

EID: 0032723797     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.6.1245     Document Type: Article

References (35)

1. Adham N, Tamm JA, Salon JA, Vaysse PJ, Weinshank RL and Branchek TA (1994). A single point mutation increases the affinity of serotonin 5-HT1D α, 5-HT1D β, 5-HT1E and 5-HT1F receptors for β-adrenergic antagonists. Neuropharmacology 33:387-391.
2. Baldwin JM, Schertler GF and Unger VM (1997) An α-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J Mol Biol 272:144-164.
3. Birdsall NJ, Cohen F, Lazareno S and Matsui H (1995) Allosteric regulation of G-protein-linked receptors. Biochem Soc Trans 23:108-111.
4. Clark AL and Mitchelson F (1976) The inhibitory effect of gallamine on muscarinic receptors. Br J Pharmacol 58:323-331.
5. Curtis CA, Wheatley M, Bansal S, Birdsall NJ, Eveleigh P, Pedder EK, Poyner D and Hulme EC (1989) Propylbenzilylcholine mustard labels an acidic residue in trans-membrane helix 3 of the muscarinic receptor. J Biol Chem 264:489-495.
6. Ellis J (1997) Allosteric binding sites on muscarinic receptors. Drug Dev Res 40:193-204.
7. Ellis J, Huyler J and Brann MR (1991) Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes. Biochem Pharmacol 42:1927-1932.
8. Ellis J, Porter DJ and Seidenberg M (1999) Separate epitopes contribute to gallamine's affinities for M1 and M5 muscarinic receptors. Life Sci 64:562.
9. Ellis J and Seidenberg M (1992) Two allosteric modulators interact at a common site on cardiac muscarinic receptors. Mol Pharmacol 42:638-641.
10. Ellis J and Seidenberg M (1999) Competitive and allosteric interactions of 6-chloro-5,10-dihydro-5-[(1-methyl-4-piperidinyl)acetyl]-11H-di benzo[b, e][1, 4]diazepine-11-one hydrochloride (UH-AH 37) at muscarinic receptors, via distinct epitopes. Biochem Pharmacol 57:181-186.
11. Ellis J, Seidenberg M and Brann MR (1993) Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. Mol Pharmacol 44:583-588.
12. Fraser CM, Wang CD, Robinson DA, Gocayne JD and Venter JC (1989) Site-directed mutagenesis of m1 muscarinic acetylcholine receptors: Conserved aspartic acids play important roles in receptor function. Mol Pharmacol 36:840-847.
13. Gharagozloo P, Lazareno S, Popham A and Birdsall NJ (1999) Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors. J Med Chem 42:438-445.
14. Glennon RA, Dukat M, Westkaemper RB, Ismaiel AM, Izzarelli DG and Parker EM (1996) The binding of propranolol at 5-hydroxytryptamine1D β T355N mutant receptors may involve formation of two hydrogen bonds to asparagine. Mol Pharmacol 49:198-206.
15. 1A receptors. Mol Pharmacol 41:695-698.
16. Jakubik J and Tucek S (1994) Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium. J Neurochem 63:1932-1940.
17. Kurtenbach E, Curtis CA, Pedder EK, Aitken A, Harris AC and Hulme EC (1990) Muscarinic acetylcholine receptors. Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation. J Biol Chem 265: 13702-13708.
18. Lee NH, Hu J and el-Fakahany EE (1992) Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the m1 muscarinic receptor. J Pharmacol Exp Ther 262:312-316.
19. 2A-adrenergic receptor. Mol Pharmacol 53:916-925.
20. Leppik RA, Miller RC, Eck M and Paquet JL (1994) Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor. Mol Pharmacol 45:983-990.
21. MacArthur MW and Thornton JM (1991) Influence of proline residues on protein conformation. J Mol Biol 218:397-412.
22. Matsui H, Lazareno S and Birdsall NJ (1995) Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis. Mol Pharmacol 47:88-98.
23. Matsui S and Fu ML (1998) Myocardial injury due to G-protein coupled receptor-autoimmunity. Jpn Heart J 39:261-274.
24. Nassif-Makki T, Trankle C, Zlotos D, Bejeuhr G, Cambareri A, Pfletschinger C, Kostenis E, Mohr K and Holzgrabe U (1999) Bisquaternary ligands of the common allosteric site of M2 acetylcholine receptors: Search for the minimum essential distances between the pharmacophoric elements. J Med Chem 42:849-858.
25. Page KM, Curtis CA, Jones PG and Hulme EC (1995) The functional role of the binding site aspartate in muscarinic acetylcholine receptors, probed by site-directed mutagenesis. Eur J Pharmacol 289:429-437.
26. Proska J and Tucek S (1994) Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors. Mol Pharmacol 46:709-717.
27. Schwartz TW, Perlman S, Rosenkilde MM and Hjorth SA (1997) How receptor mutagenesis may confirm or confuse receptor classification. Ann NY Acad Sci 812:71-84.
28. Spalding TA, Birdsall NJ, Curtis CA and Hulme EC (1994) Acetylcholine mustard labels the binding site aspartate in muscarinic acetylcholine receptors. J Biol Chem 269:4092-4097.
29. Spalding TA, Burstein ES, Wells JW and Brann MR (1997) Constitutive activation of the m5 muscarinic receptor by a series of mutations at the extracellular end of transmembrane 6. Biochemistry 36:10109-10116.
30. Stockton JM, Birdsall NJ, Burgen AS and Hulme EC (1983) Modification of the binding properties of muscarinic receptors by gallamine. Mol Pharmacol 23:551-557.
31. Strader CD, Fong TM, Tota MR, Underwood D and Dixon RA (1994) Structure and function of G protein-coupled receptors. Annu Rev Biochem 63:101-132.
32. Strader CD, Sigal IS, Register RB, Candelore MR, Rands E and Dixon RA (1987) Identification of residues required for ligand binding to the β-adrenergic receptor. Proc Natl Acad Sci USA 84:4384-4388.
33. Suryanarayana S, Daunt DA, Von Zastrow M and Kobilka BK (1991) A point mutation in the seventh hydrophobic domain of the α2 adrenergic receptor increases its affinity for a family of β receptor antagonists. J Biol Chem 266:15488-15492.
34. Trankle C, Kostenis E, Burgmer U and Mohr K (1996) Search for lead structures to develop new allosteric modulators of muscarinic receptors. J Pharmacol Exp Ther 279:926-933.
35. Waelbroeck M (1994) Identification of drugs competing with D-tubocurarine for an allosteric site on cardiac muscarinic receptors. Mol Pharmacol 46:685-692.